
Engenac 75mg Injection
Marketer
NG Healthcare Pvt Ltd
Salt Composition
Diclofenac (75mg)
Overview Engenac 75mg Injection
Arthalgin 75mg Injection provides analgesia. This injectable medication addresses pain, inflammation, rigidity, and arthritic discomfort in conditions such as rheumatoid and osteoarthritis, plus acute musculoskeletal trauma. Parenteral administration is indicated when oral intake is infeasible. Arthalgin 75mg Injection must be given by a medical professional; self-injection is strictly prohibited. Prior heart conditions or strokes should be disclosed to your physician. Report any injection site reactions (pain, swelling, erythema) immediately. Common adverse effects include nausea, emesis, cephalalgia, and local injection reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with hematological parameters. Chronic use carries a risk of gastrointestinal hemorrhage and nephropathy.
Uses of Engenac 75mg Injection
Analgesia
Major Benefits of Engenac 75mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Engenac 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Engenac 75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Engenac 75mg Injection works:
Engenac 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated signs of inflammation, such as redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Engenac 75mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Engenac 75mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The administration of Engenac 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Engenac 75mg Injection may induce adverse reactions that could impair driving capabilities.
KidneyCAUTION
Patients with kidney impairment should use Engenac 75mg Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
The administration of Engenac 75mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Engenac 75mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Engenac 75mg Injection :
Omit a dose of Engenac 75mg Injection? Seek your physician's advice.
Facts to Know About Engenac 75mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic acid derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
